Description:

KRBP refers to Kores BioPharmaceuticals Corp., a company listed on the New York Stock Exchange (NYSE). Kores BioPharmaceuticals Corp. is engaged in the development and commercialization of innovative biopharmaceutical products aimed at addressing unmet medical needs in various therapeutic areas. The company focuses on leveraging its proprietary technologies to bring forward novel treatments that can improve patient outcomes. Investors interested in the biotechnology sector might find KRBP an intriguing option due to its potential for growth and innovation within the pharmaceutical industry.

Data:

Yields: